Insider Trading & Ownership - Iterum Therapeutics plc (ITRM)

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Iterum Therapeutics plc
Goto 0, 1, 2, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2023-12-22
Purchase
2023-12-27
09:00 am
Iterum Therapeutics plcITRMDunne Michael W.
Director
25,000$1.4$35,000113,754
(Direct)
View
2023-12-18
Purchase
2023-12-19
4:15 pm
Iterum Therapeutics plcITRMDunne Michael W.
Director
10,000$1.8442$18,44288,754
(Direct)
View
2023-11-22
Purchase
2023-11-27
5:00 pm
Iterum Therapeutics plcITRMDunne Michael W.
Director
20,000$2.0345$40,69078,754
(Direct)
View
2023-11-20
Purchase
2023-11-20
5:00 pm
Iterum Therapeutics plcITRMFishman Corey N.
Chief Executive Officer
10,000$1.5863$15,86354,449
(Direct)
View
2022-12-02
Sale
2022-12-05
5:00 pm
Iterum Therapeutics plcITRMPuttagunta Sailaja
Chief Medical Officer
3,365$1.32$4,44229,968
(Direct)
View
2022-09-16
Sale
2022-09-20
6:00 pm
Iterum Therapeutics plcITRMAhrens Brenton Karl
Director
37,246$1.8238$67,930410
(Indirect
Direct)
View
2022-09-13
Sale
2022-09-15
5:36 pm
Iterum Therapeutics plcITRMAhrens Brenton Karl
Director
45,000$2.0855$93,84637,656
(Indirect
Direct)
View
2022-09-08
Sale
2022-09-12
9:01 pm
Iterum Therapeutics plcITRMAhrens Brenton Karl
Director
33,298$2.3065$76,80382,656
(Indirect
Direct)
View
2022-09-07
Purchase
2022-09-09
6:00 pm
Iterum Therapeutics plcITRMDunne Michael W.
Director
10,000$2.22$22,20035,576
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2023-12-01
Exercise
2023-12-04
5:00 pm
N/A
N/A
Iterum Therapeutics plcITRMPuttagunta Sailaja
Chief Medical Officer
8,333$027,035
(Direct)
View
2023-12-01
Option Award
2023-12-04
5:00 pm
N/A
N/A
Iterum Therapeutics plcITRMPuttagunta Sailaja
Chief Medical Officer
8,333$027,035
(Direct)
View
2023-12-01
Tax Withholding
2023-12-04
5:00 pm
N/A
N/A
Iterum Therapeutics plcITRMPuttagunta Sailaja
Chief Medical Officer
2,933$2.1227,035
(Direct)
View
2023-10-01
Exercise
2023-10-02
09:22 am
N/A
N/A
Iterum Therapeutics plcITRMHUNT RONALD
Director
5,479$0111,432
(Direct)
View
2023-10-01
Exercise
2023-10-02
09:20 am
N/A
N/A
Iterum Therapeutics plcITRMDunne Michael W.
Director
3,487$058,754
(Direct)
View
2023-07-01
Exercise
2023-07-03
08:00 am
N/A
N/A
Iterum Therapeutics plcITRMDunne Michael W.
Director
1,779$055,267
(Direct)
View
2023-07-01
Exercise
2023-07-03
08:00 am
N/A
N/A
Iterum Therapeutics plcITRMHUNT RONALD
Director
2,796$0105,953
(Direct)
View
2023-06-15
Exercise
2023-06-15
5:00 pm
N/A
N/A
Iterum Therapeutics plcITRMHecht Beth
Director
15,853$018,839
(Direct)
View
2023-06-15
Exercise
2023-06-15
5:00 pm
N/A
N/A
Iterum Therapeutics plcITRMDunne Michael W.
Director
15,853$053,488
(Direct)
View
2023-06-15
Exercise
2023-06-15
5:00 pm
N/A
N/A
Iterum Therapeutics plcITRMChin Mark
Director
15,853$018,306
(Direct)
View
2023-04-01
Exercise(A)
2023-06-05
08:00 am
N/A
N/A
Iterum Therapeutics plcITRMDunne Michael W.
Director
1,299$037,635
(Direct)
View
2023-04-01
Exercise
2023-04-03
8:00 pm
N/A
N/A
Iterum Therapeutics plcITRMHUNT RONALD
Director
2,041$06,071
(Direct)
View
2023-03-31
Option Award
2023-04-03
8:00 pm
N/A
2033-03-30
Iterum Therapeutics plcITRMMatthews Judith M.
Chief Financial Officer
100,000$0100,000
(Direct)
View
2023-03-31
Option Award
2023-04-03
8:00 pm
N/A
2033-03-30
Iterum Therapeutics plcITRMPuttagunta Sailaja
Chief Medical Officer
75,000$075,000
(Direct)
View
2023-04-01
Exercise
2023-04-03
8:00 pm
N/A
N/A
Iterum Therapeutics plcITRMDunne Michael W.
Director
1,299$037,636
(Direct)
View
2023-03-31
Option Award
2023-04-03
8:00 pm
N/A
2033-03-30
Iterum Therapeutics plcITRMFishman Corey N.
Chief Executive Officer
275,000$0275,000
(Direct)
View
2023-03-11
Exercise
2023-03-14
6:00 pm
N/A
N/A
Iterum Therapeutics plcITRMMatthews Judith M.
Chief Financial Officer
6,666$08,135
(Direct)
View
2023-03-11
Option Award
2023-03-14
6:00 pm
N/A
N/A
Iterum Therapeutics plcITRMMatthews Judith M.
Chief Financial Officer
6,666$08,135
(Direct)
View
2023-03-11
Tax Withholding
2023-03-14
6:00 pm
N/A
N/A
Iterum Therapeutics plcITRMMatthews Judith M.
Chief Financial Officer
2,883$0.968,135
(Direct)
View
2023-03-11
Exercise
2023-03-14
6:00 pm
N/A
N/A
Iterum Therapeutics plcITRMFishman Corey N.
Chief Executive Officer
14,333$044,449
(Direct)
View
2023-03-11
Option Award
2023-03-14
6:00 pm
N/A
N/A
Iterum Therapeutics plcITRMFishman Corey N.
Chief Executive Officer
14,333$044,449
(Direct)
View
2023-03-11
Tax Withholding
2023-03-14
6:00 pm
N/A
N/A
Iterum Therapeutics plcITRMFishman Corey N.
Chief Executive Officer
5,683$0.9644,449
(Direct)
View
2023-01-01
Exercise
2023-01-04
6:00 pm
N/A
N/A
Iterum Therapeutics plcITRMDunne Michael W.
Director
761$036,337
(Direct)
View
2023-01-01
Exercise
2023-01-04
6:00 pm
N/A
N/A
Iterum Therapeutics plcITRMHUNT RONALD
Director
1,197$0101,116
(Direct)
View
2022-12-23
Option Award
2022-12-28
9:00 pm
N/A
2032-12-22
Iterum Therapeutics plcITRMAhrens Brenton Karl
Director
29,125$0.8129,125
(Direct)
View
2022-12-23
Option Award
2022-12-28
9:00 pm
N/A
N/A
Iterum Therapeutics plcITRMHUNT RONALD
Director
5,479$05,479
(Direct)
View
2022-12-23
Option Award
2022-12-28
9:00 pm
N/A
N/A
Iterum Therapeutics plcITRMDunne Michael W.
Director
3,487$03,487
(Direct)
View
2022-12-01
Exercise
2022-12-05
5:00 pm
N/A
N/A
Iterum Therapeutics plcITRMPuttagunta Sailaja
Chief Medical Officer
8,334$029,968
(Direct)
View
2022-12-01
Option Award
2022-12-05
5:00 pm
N/A
N/A
Iterum Therapeutics plcITRMPuttagunta Sailaja
Chief Medical Officer
8,334$029,968
(Direct)
View
2022-09-25
Option Award
2022-09-28
06:12 am
N/A
2032-09-24
Iterum Therapeutics plcITRMAhrens Brenton Karl
Director
14,838$1.5914,838
(Direct)
View
2022-09-25
Option Award
2022-09-27
9:00 pm
N/A
N/A
Iterum Therapeutics plcITRMDunne Michael W.
Director
1,779$01,779
(Direct)
View
2022-09-25
Option Award
2022-09-27
9:00 pm
N/A
N/A
Iterum Therapeutics plcITRMHUNT RONALD
Director
2,796$02,796
(Direct)
View
2022-06-25
Option Award
2022-06-28
9:00 pm
N/A
2032-06-24
Iterum Therapeutics plcITRMAhrens Brenton Karl
Director
113,276$0113,276
(Direct)
View
2022-06-25
Option Award
2022-06-28
9:00 pm
N/A
N/A
Iterum Therapeutics plcITRMHUNT RONALD
Director
30,623$030,623
(Direct)
View
2022-06-25
Option Award
2022-06-28
9:00 pm
N/A
N/A
Iterum Therapeutics plcITRMDunne Michael W.
Director
19,488$019,488
(Direct)
View
2022-06-23
Exercise
2022-06-24
6:00 pm
N/A
N/A
Iterum Therapeutics plcITRMHUNT RONALD
Director
36,798$01,498,804
(Direct)
View
2022-06-23
Exercise
2022-06-24
6:00 pm
N/A
N/A
Iterum Therapeutics plcITRMChin Mark
Director
36,798$036,798
(Direct)
View
2022-06-23
Exercise
2022-06-24
6:00 pm
N/A
N/A
Iterum Therapeutics plcITRMDunne Michael W.
Director
36,798$0383,647
(Direct)
View
(A) Indicate amendment filing.
Goto 0, 1, 2, Next